Merck KGaA (XSWX:MER) Total Noninterest Expense


XSWX:MER Merck KGaA XSWX:MER
84 GF Score
Price CHF132.00
GF Value CHF132.97
! 10 Warning Signs
View Full Analysis

What is Merck KGaA Total Noninterest Expense?

Total Noninterest Expense only applies to banks.

XSWX:MER
84GF Score
Merck KGaA XSWX:MER
Total Noninterest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck KGaA (XSWX:MER) Overvalued in 2026?

Based on GuruFocus' analysis, Merck KGaA stock appears to be undervalued. The current stock price of CHF132.00 is trading 0.7% below its estimated GF Value™ of CHF132.97.

Key valuation signals for XSWX:MER:

  • Total Noninterest Expense:
  • GF Value™: CHF132.97 vs. price of CHF132.00 (0.7% below fair value)
  • GF Score™: 84/100 with 10 warning signs

No single metric tells the full story. See the XSWX:MER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merck KGaA Business Description

Address Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
84GF Score

Get the complete analysis for XSWX:MER

Total Noninterest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF132.00
Price
CHF132.97
GF Value